Dare Bioscience, Inc. (DARE)

NASDAQ: DARE · IEX Real-Time Price · USD
1.24
0.00 (0.00%)
At close: Jul 6, 2022 4:00 PM
1.27
+0.03 (2.42%)
After-hours: Jul 6, 2022 7:44 PM EDT

Income Statement (Quarterly)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Quarter Ended 2022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
Revenue
00000000000000000000000000000000.030.050.01000
Gross Profit
00000000000000000000000000000000.030.050.01000
Selling, General & Admin
2.572.42.211.81.941.781.351.561.861.361.321.311.281.021.181.161.30.981.050.480.20.040.012.773.122.872.952.722.682.612.442.031.511.581.231.391.97
Research & Development
5.817.1210.437.345.736.646.25.552.382.371.972.511.691.661.452.221.090.670.2800.03007.529.777.167.096.685.024.72.932.651.51.441.593.23.48
Other Operating Expenses
0.030.030.030.030.030.030.030.020.010.130.130.160.110.2800.255.297.490000.15000000000000000
Operating Expenses
8.49.5412.679.167.698.447.587.134.253.863.423.983.082.962.623.627.689.141.330.480.230.190.0110.312.8910.0310.059.47.77.315.374.683.013.022.814.595.45
Operating Income
-8.4-9.54-12.67-9.16-7.69-8.44-7.58-7.13-4.25-3.86-3.42-3.98-3.08-2.96-2.62-3.62-7.68-9.14-1.33-0.48-0.23-0.19-0.01-10.3-12.89-10.03-10.05-9.4-7.7-7.31-5.37-4.64-2.96-3.01-2.81-4.59-5.45
Interest Expense / Income
0000000000000000000000.010.010.60.660.690.510.510.720.160.190.270.460.430.380.330.35
Other Expense / Income
-0-0-0-0-0.3700-0-00.01-0.03-0.03-0.03-0.04-0.05-0.04-0.01-0.010.30.020.0200-0.03-0.01-0.01-0-00.01-0-02.49-0.510.040.01-0.02-0.23
Pretax Income
-8.4-9.54-12.67-9.16-7.32-8.44-7.58-7.12-4.25-3.87-3.39-3.95-3.05-2.92-2.57-3.58-7.67-9.13-1.63-0.5-0.24-0.2-0.02-10.86-13.54-10.71-10.55-9.91-8.43-7.47-5.56-7.4-2.91-3.48-3.2-4.89-5.57
Net Income
-8.4-9.54-12.67-9.16-7.32-8.44-7.58-7.12-4.25-3.87-3.39-3.95-3.05-2.92-2.57-3.58-7.67-9.13-1.63-0.5-0.24-0.2-0.02-10.86-13.54-10.71-10.55-9.91-8.43-7.47-5.56-7.4-2.91-3.48-3.2-4.89-5.57
Preferred Dividends
0000000.0100000.790000000000000000000000000
Net Income Common
-8.4-9.54-12.67-9.16-7.32-8.44-7.59-7.12-4.25-3.87-3.39-4.74-3.05-2.92-2.57-3.58-7.67-9.13-1.63-0.5-0.24-0.2-0.02-10.86-13.54-10.71-10.55-9.91-8.43-7.47-5.56-7.4-2.91-3.48-3.2-4.89-5.57
Shares Outstanding (Basic)
84527150453032272418171611111111935111133333212200000
Shares Outstanding (Diluted)
84527150453032272418171611111111935111133333212200000
Shares Change
88.63%72.90%124.06%88.83%86.99%66.74%89.34%65.85%108.36%57.90%46.06%41.00%31.52%253.61%129.07%1155.18%854.35%280.97%500.38%-66.75%-66.74%-69.00%-69.59%2.52%34.46%88.11%35.69%58.09%2485.87%1761.42%2668.20%2646.84%28.42%----
EPS (Basic)
-0.10-0.18-0.18-0.18-0.16-0.22-0.24-0.27-0.18-0.21-0.20-0.29-0.27-0.25-0.23-0.32-0.88-2.52-0.33-0.55-0.27-0.23-0.02-3.97-4.90-3.90-3.90-3.70-4.10-3.40-2.80-4.40-37.00-40.90-44.00-79.60-90.90
EPS (Diluted)
-0.10-0.18-0.18-0.18-0.16-0.22-0.24-0.27-0.18-0.21-0.20-0.29-0.27-0.25-0.23-0.32-0.88-2.52-0.33-0.55-0.27-0.23-0.02-3.97-4.90-3.90-3.90-3.70-4.10-3.40-2.80-4.40-37.00-40.90-44.00-79.60-90.90
Free Cash Flow Per Share
-0.15-0.190.02-0.23-0.19-0.31-0.17-0.15-0.28-0.21-0.19-0.19-0.29-0.24-0.24-0.23-0.24-0.30-0.28-1.77-0.06-0.1930.20-4.15-4.98-3.04-2.93-2.95-3.92-3.93-2.80-2.50-46.63-41.85-44.32-89.87-75.13
Gross Margin
-------------------------------100.00%100.00%100.00%---
Operating Margin
--------------------------------14072.73%-6293.62%-50150.00%---
Profit Margin
--------------------------------22433.33%-6200.00%-58000.00%---
Free Cash Flow Margin
--------------------------------12796.97%-7808.51%-54516.67%---
EBITDA
-8.4-9.56-12.69-9.18-7.34-8.47-7.61-7.15-4.3-3.87-3.41-3.95-3.05-2.91-2.57-3.58-7.67-9.13-1.63-0.5-0.24-0.19-0.13-10.2-12.82-9.96-10-9.35-7.67-7.27-5.34-7.11-2.42-3.02-2.78-4.52-5.15
EBITDA Margin
--------------------------------21539.39%-5142.55%-50266.67%---
Depreciation & Amortization
-0-0.02-0.02-0.01-0.02-0.03-0.02-0.02-0.04-0-0.02000.0100000000-0.130.070.060.060.050.040.040.030.030.030.040.030.040.050.07
EBIT
-8.4-9.54-12.67-9.16-7.32-8.44-7.58-7.12-4.25-3.87-3.39-3.95-3.05-2.92-2.57-3.58-7.67-9.13-1.63-0.5-0.24-0.19-0.01-10.26-12.88-10.02-10.04-9.39-7.71-7.3-5.37-7.14-2.45-3.05-2.82-4.57-5.22
EBIT Margin
--------------------------------21621.21%-5219.15%-50833.33%---
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).